[go: up one dir, main page]

WO2003009885A3 - Hemofiltration systems, methods and devices used to treat inflammatory mediator related disease - Google Patents

Hemofiltration systems, methods and devices used to treat inflammatory mediator related disease Download PDF

Info

Publication number
WO2003009885A3
WO2003009885A3 PCT/US2002/023603 US0223603W WO03009885A3 WO 2003009885 A3 WO2003009885 A3 WO 2003009885A3 US 0223603 W US0223603 W US 0223603W WO 03009885 A3 WO03009885 A3 WO 03009885A3
Authority
WO
WIPO (PCT)
Prior art keywords
stream
ultrafiltrate
related disease
methods
inflammatory mediator
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2002/023603
Other languages
French (fr)
Other versions
WO2003009885A2 (en
Inventor
James R Matson
Patrice A Lee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunocept LLC
Original Assignee
Immunocept LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/912,904 external-priority patent/US6730266B2/en
Application filed by Immunocept LLC filed Critical Immunocept LLC
Priority to EP02750294A priority Critical patent/EP1409041A4/en
Priority to AU2002319690A priority patent/AU2002319690A1/en
Publication of WO2003009885A2 publication Critical patent/WO2003009885A2/en
Publication of WO2003009885A3 publication Critical patent/WO2003009885A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
    • A61M1/3486—Biological, chemical treatment, e.g. chemical precipitation; treatment by absorbents

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A hemofiltration system for a mammal comprises a hemofilter and an adsorbent device. The hemofilter removes ultrafiltrate from a blood stream extracted from the mammal to create a filtered blood stream and an ultrafiltrate stream. The adsorbent device is comprised of one or more adsorbent materials and is used to adsorb inflammatory mediators from the ultrafiltrate stream received from the hemofilter removing inflammatory mediators that cause inflammatory mediator related disease, sepsis, and SIRS/MODS/MOSF to create a post adsorption ultrafiltrate stream. The post adsorption ultrafiltrate stream is selectively combined with the filtered blood stream and together with the filtered blood stream is returned to the mammal.
PCT/US2002/023603 2001-07-25 2002-07-24 Hemofiltration systems, methods and devices used to treat inflammatory mediator related disease Ceased WO2003009885A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP02750294A EP1409041A4 (en) 2001-07-25 2002-07-24 Hemofiltration systems, methods and devices used to treat inflammatory mediator related disease
AU2002319690A AU2002319690A1 (en) 2001-07-25 2002-07-24 Hemofiltration systems, methods and devices used to treat inflammatory mediator related disease

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/912,904 US6730266B2 (en) 1998-07-10 2001-07-25 Hemofiltration systems, methods and devices used to treat inflammatory mediator related disease
US09/912,904 2001-07-25

Publications (2)

Publication Number Publication Date
WO2003009885A2 WO2003009885A2 (en) 2003-02-06
WO2003009885A3 true WO2003009885A3 (en) 2003-07-03

Family

ID=25432668

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/023603 Ceased WO2003009885A2 (en) 2001-07-25 2002-07-24 Hemofiltration systems, methods and devices used to treat inflammatory mediator related disease

Country Status (3)

Country Link
EP (1) EP1409041A4 (en)
AU (1) AU2002319690A1 (en)
WO (1) WO2003009885A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8038638B2 (en) 2004-02-23 2011-10-18 Hemolife Medical, Inc. Plasma detoxification and volume control system and methods of use
US8339447B2 (en) 2004-10-21 2012-12-25 Truevision Systems, Inc. Stereoscopic electronic microscope workstation
ATE477009T1 (en) * 2007-01-12 2010-08-15 Bellco Srl KIT FOR THE TREATMENT OF DISEASES RELATED TO SYSTEMIC INFLAMMATION
EP2352568B1 (en) * 2008-10-02 2017-11-29 University of Pittsburgh - Of the Commonwealth System of Higher Education Administration of an adsorbent polymer for treatment of systemic inflammation
US20170266362A1 (en) 2014-08-26 2017-09-21 3M Innovative Properties Company System for removal of pro-inflammatory mediators as well as granulocytes and monocytes from blood

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0098392A2 (en) * 1982-07-02 1984-01-18 Gambro Dialysatoren GmbH & Co. KG Filtration membrane and process for producing the membrane
US4844810A (en) * 1986-08-08 1989-07-04 Hospal Industrie Installation with multiple functions for replacement of the natural filtration of the blood
US5536412A (en) * 1992-02-06 1996-07-16 Hemocleanse, Inc. Hemofiltration and plasmafiltration devices and methods
US5571418A (en) * 1993-08-20 1996-11-05 Lee; Patrice A. Hemofiltration of toxic mediator-related disease
EP0787500A1 (en) * 1996-02-06 1997-08-06 BELLCO S.p.A. Method and device for extracorporeal removal of toxins, in particular cytokines
US5858238A (en) * 1996-03-08 1999-01-12 Baxter Research Medical, Inc. Salvage of autologous blood via selective membrane/sorption technologies

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6287516B1 (en) * 1998-07-10 2001-09-11 Immunocept, L.L.C. Hemofiltration systems, methods, and devices used to treat inflammatory mediator related disease

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0098392A2 (en) * 1982-07-02 1984-01-18 Gambro Dialysatoren GmbH & Co. KG Filtration membrane and process for producing the membrane
US4844810A (en) * 1986-08-08 1989-07-04 Hospal Industrie Installation with multiple functions for replacement of the natural filtration of the blood
US5536412A (en) * 1992-02-06 1996-07-16 Hemocleanse, Inc. Hemofiltration and plasmafiltration devices and methods
US5571418A (en) * 1993-08-20 1996-11-05 Lee; Patrice A. Hemofiltration of toxic mediator-related disease
EP0787500A1 (en) * 1996-02-06 1997-08-06 BELLCO S.p.A. Method and device for extracorporeal removal of toxins, in particular cytokines
US5858238A (en) * 1996-03-08 1999-01-12 Baxter Research Medical, Inc. Salvage of autologous blood via selective membrane/sorption technologies

Also Published As

Publication number Publication date
WO2003009885A2 (en) 2003-02-06
AU2002319690A1 (en) 2003-02-17
EP1409041A2 (en) 2004-04-21
EP1409041A4 (en) 2007-05-16

Similar Documents

Publication Publication Date Title
WO2000002603A3 (en) Hemofiltration systems, methods, and devices used to treat inflammatory mediator related disease
US8672869B2 (en) Kit, system and method of treating myeloma patients
De Vriese et al. Can inflammatory cytokines be removed efficiently by continuous renal replacement therapies?
WO2000062836A3 (en) Method of removing beta-2 microglobulin from blood
WO2003051422A3 (en) Wearable peritoneal dialysis system
WO2002043859A3 (en) Cartridges useful in cleaning dialysis solutions
US20060186044A1 (en) Machine for plasma purification combined with plasma adsorption-perfusion by using a tricompartmental dialyzer
WO2004024284A3 (en) Method of purifying polypeptides by simulated moving bed chromatography
CA2401577A1 (en) System, device and method for rapid packet filtering and processing
GB0317839D0 (en) Solvent removal process
DE3852187D1 (en) High performance breathing filter.
Papamichalis et al. Liver replacement therapy with extracorporeal blood purification techniques current knowledge and future directions
CA2223236A1 (en) Method for purifying thrombopoietin
WO2003009885A3 (en) Hemofiltration systems, methods and devices used to treat inflammatory mediator related disease
EP0884383A4 (en) PROCESS FOR THE PURIFICATION AND REMOVAL OF VIRUSES
ES2105033T3 (en) PROTEIN PURIFICATION METHOD.
ES2040684T3 (en) METHOD FOR THE REGENERATION OF A TANINO ADSORBENT.
DE60129904D1 (en) Adsorbent, adsorption and removal process and adsorber for endogenous canabinoid
WO2006026219A3 (en) Context-aware filter for participants in persistent communication
WO2010082064A3 (en) Extracorporeal blood filtration
WO2004101158A3 (en) Magnetic molecules: process utilizing functionalized magnetic ferritins for the selective removal of contaminants from solution by magnetic filtration
RU96113402A (en) METHOD FOR BLOOD DETOXICATION
Nalesso Plasma filtration adsorption dialysis (PFAD): a new technology for blood purification
Cormier et al. Phenytoin overdose treated with hemodialysis using a high cut‐off dialyzer
CN211884748U (en) A hemofiltration machine with multi-layer protection

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GM HR HU ID IL IN IS JP KE KG KP KZ LC LK LR LS LT LU LV MA MD MK MN MW MX MZ NO NZ OM PH PT RO RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG UZ VN YU ZA ZM

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ CZ DE DE DK DK DM DZ EC EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SK SL TJ TM TN TR TT TZ UA UG UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2002750294

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2002750294

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP